Joyce Pauline Joseph
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Joyce Pauline Joseph has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Jamuna Rani Appalasamy
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Malaysia
5 shared publications - Siva Seeta Ramaiah
Medical Department Subang Jaya Medical Center Sunway Malaysia
5 shared publications - Anuar Zaini Md Zain
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
3 shared publications - Kia Fatt Quek
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Malaysia
3 shared publications - Kyi Kyi Tha
Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia
3 shared publications - Kit Mun Tan
Universiti Malaya Wilayah Persekutuan Kuala Lumpur Malaysia
2 shared publications
Latest Publications
- Open Access
- 13 June 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (4) , 416-418
A Rare Case of Late- Onset Task-Specific Jaw Tremor
Lau YH, et al. J Clin Neurol. 2023 Jun;19:e48. https://doi.org/10.3988/jcn.2022.0202
- 13 June 2023
- Published by XMLink in Journal of Clinical Neurology
- Vol. 19 (4) , 416-418
Open AccessA Rare Case of Late- Onset Task-Specific Jaw Tremor
Lau YH, et al. J Clin Neurol. 2023 Jun;19:e48. https://doi.org/10.3988/jcn.2022.0202
- 1 January 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (1) , 105427
COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems
- 1 January 2021
- Published by Elsevier in Journal of Stroke and Cerebrovascular Diseases
- Vol. 30 (1) , 105427
COVID-19 and Major Organ Thromboembolism: Manifestations in Neurovascular and Cardiovascular Systems
- Open Access
- 10 July 2020
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 3 (2) , e17182
Video Narratives Intervention Among Stroke Survivors: Feasibility and Acceptability Study of a Randomized Controlled Trial
Background: A large number of stroke survivors worldwide suffer from moderate to severe disability. In Malaysia, long-term uncontrolled stroke risk factors lead to unforeseen rates of recurrent stroke and a growing incidence of stroke occurrence across ages, predominantly among the elderly population. This situation has motivated research efforts focused on tapping into patient education, especially related to patient self-efficacy of understanding and taking medication appropriately. Video narratives integrated with health belief model constructs have demonstrated potential impacts as an aide to patient education efforts. Objective: The aim of this study was to investigate the feasibility and acceptability of study procedures based on a randomized controlled trial protocol of a video narratives intervention among poststroke patients. We also aimed to obtain preliminary findings of video narratives related to medication understanding and use self-efficacy (MUSE) and blood pressure control. Methods: A parallel group randomized controlled trial including a control group (without video viewing) and an intervention group (with video viewing) was conducted by researchers at a neurology outpatient clinic on poststroke patients (N=54). Baseline data included patients’ sociodemographic characteristics, medical information, and all outcome measures. Measurements of MUSE and blood pressure following the trial were taken during a 3-month follow-up period. Feasibility of the trial was assessed based on recruitment and study completion rates along with patients’ feedback on the burden of the study procedures and outcome measures. Acceptability of the trial was analyzed qualitatively. Statistical analysis was applied to ascertain the preliminary results of video narratives. Results: The recruitment rate was 60 out of 117 patients (51.3%). Nevertheless, the dropout rate of 10% was within the acceptable range. Patients were aged between 21 and 74 years. Nearly 50 of the patients (>85%) had adequate health literacy and exposure to stroke education. Most of the patients (>80%) were diagnosed with ischemic stroke, whereby the majority had primary hypertension. The technicalities of randomization and patient approach were carried out with minimal challenge and adequate patient satisfaction. The video contents received good responses with respect to comprehension and simplicity. Moreover, an in-depth phone interview with 8 patients indicated that the video narratives were considered to be useful and inspiring. These findings paralleled the preliminary findings of significant improvement within groups in MUSE (P=.001) and systolic blood pressure control (P=.04). Conclusions: The queries and feedback from each phase in this study have been acknowledged and will be taken forward in the full trial. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN 12618000174280; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373554
- 10 July 2020
- Published by JMIR Publications Inc. in JMIR Aging
- Vol. 3 (2) , e17182
Open AccessVideo Narratives Intervention Among Stroke Survivors: Feasibility and Acceptability Study of a Randomized Controlled Trial
Background: A large number of stroke survivors worldwide suffer from moderate to severe disability. In Malaysia, long-term uncontrolled stroke risk factors lead to unforeseen rates of recurrent stroke and a growing incidence of stroke occurrence across ages, predominantly among the elderly population. This situation has motivated research efforts focused on tapping into patient education, especially related to patient self-efficacy of understanding and taking medication appropriately. Video narratives integrated with health belief model constructs have demonstrated potential impacts as an aide to patient education efforts. Objective: The aim of this study was to investigate the feasibility and acceptability of study procedures based on a randomized controlled trial protocol of a video narratives intervention among poststroke patients. We also aimed to obtain preliminary findings of video narratives related to medication understanding and use self-efficacy (MUSE) and blood pressure control. Methods: A parallel group randomized controlled trial including a control group (without video viewing) and an intervention group (with video viewing) was conducted by researchers at a neurology outpatient clinic on poststroke patients (N=54). Baseline data included patients’ sociodemographic characteristics, medical information, and all outcome measures. Measurements of MUSE and blood pressure following the trial were taken during a 3-month follow-up period. Feasibility of the trial was assessed based on recruitment and study completion rates along with patients’ feedback on the burden of the study procedures and outcome measures. Acceptability of the trial was analyzed qualitatively. Statistical analysis was applied to ascertain the preliminary results of video narratives. Results: The recruitment rate was 60 out of 117 patients (51.3%). Nevertheless, the dropout rate of 10% was within the acceptable range. Patients were aged between 21 and 74 years. Nearly 50 of the patients (>85%) had adequate health literacy and exposure to stroke education. Most of the patients (>80%) were diagnosed with ischemic stroke, whereby the majority had primary hypertension. The technicalities of randomization and patient approach were carried out with minimal challenge and adequate patient satisfaction. The video contents received good responses with respect to comprehension and simplicity. Moreover, an in-depth phone interview with 8 patients indicated that the video narratives were considered to be useful and inspiring. These findings paralleled the preliminary findings of significant improvement within groups in MUSE (P=.001) and systolic blood pressure control (P=.04). Conclusions: The queries and feedback from each phase in this study have been acknowledged and will be taken forward in the full trial. Trial Registration: Australian New Zealand Clinical Trials Registry ACTRN 12618000174280; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373554
- Open Access
- 24 November 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Video Narratives Intervention Among Stroke Survivors: Feasibility and Acceptability Study of a Randomized Controlled Trial (Preprint)
BACKGROUND A large number of stroke survivors worldwide suffer from moderate to severe disability. In Malaysia, long-term uncontrolled stroke risk factors lead to unforeseen rates of recurrent stroke and a growing incidence of stroke occurrence across ages, predominantly among the elderly population. This situation has motivated research efforts focused on tapping into patient education, especially related to patient self-efficacy of understanding and taking medication appropriately. Video narratives integrated with health belief model constructs have demonstrated potential impacts as an aide to patient education efforts. OBJECTIVE The aim of this study was to investigate the feasibility and acceptability of study procedures based on a randomized controlled trial protocol of a video narratives intervention among poststroke patients. We also aimed to obtain preliminary findings of video narratives related to medication understanding and use self-efficacy (MUSE) and blood pressure control. METHODS A parallel group randomized controlled trial including a control group (without video viewing) and an intervention group (with video viewing) was conducted by researchers at a neurology outpatient clinic on poststroke patients (N=54). Baseline data included patients’ sociodemographic characteristics, medical information, and all outcome measures. Measurements of MUSE and blood pressure following the trial were taken during a 3-month follow-up period. Feasibility of the trial was assessed based on recruitment and study completion rates along with patients’ feedback on the burden of the study procedures and outcome measures. Acceptability of the trial was analyzed qualitatively. Statistical analysis was applied to ascertain the preliminary results of video narratives. RESULTS The recruitment rate was 60 out of 117 patients (51.3%). Nevertheless, the dropout rate of 10% was within the acceptable range. Patients were aged between 21 and 74 years. Nearly 50 of the patients (>85%) had adequate health literacy and exposure to stroke education. Most of the patients (>80%) were diagnosed with ischemic stroke, whereby the majority had primary hypertension. The technicalities of randomization and patient approach were carried out with minimal challenge and adequate patient satisfaction. The video contents received good responses with respect to comprehension and simplicity. Moreover, an in-depth phone interview with 8 patients indicated that the video narratives were considered to be useful and inspiring. These findings paralleled the preliminary findings of significant improvement within groups in MUSE (P=.001) and systolic blood pressure control (P=.04). CONCLUSIONS The queries and feedback from each phase in this study have been acknowledged and will be taken forward in the full trial. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN 12618000174280; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373554
- 24 November 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessVideo Narratives Intervention Among Stroke Survivors: Feasibility and Acceptability Study of a Randomized Controlled Trial (Preprint)
BACKGROUND A large number of stroke survivors worldwide suffer from moderate to severe disability. In Malaysia, long-term uncontrolled stroke risk factors lead to unforeseen rates of recurrent stroke and a growing incidence of stroke occurrence across ages, predominantly among the elderly population. This situation has motivated research efforts focused on tapping into patient education, especially related to patient self-efficacy of understanding and taking medication appropriately. Video narratives integrated with health belief model constructs have demonstrated potential impacts as an aide to patient education efforts. OBJECTIVE The aim of this study was to investigate the feasibility and acceptability of study procedures based on a randomized controlled trial protocol of a video narratives intervention among poststroke patients. We also aimed to obtain preliminary findings of video narratives related to medication understanding and use self-efficacy (MUSE) and blood pressure control. METHODS A parallel group randomized controlled trial including a control group (without video viewing) and an intervention group (with video viewing) was conducted by researchers at a neurology outpatient clinic on poststroke patients (N=54). Baseline data included patients’ sociodemographic characteristics, medical information, and all outcome measures. Measurements of MUSE and blood pressure following the trial were taken during a 3-month follow-up period. Feasibility of the trial was assessed based on recruitment and study completion rates along with patients’ feedback on the burden of the study procedures and outcome measures. Acceptability of the trial was analyzed qualitatively. Statistical analysis was applied to ascertain the preliminary results of video narratives. RESULTS The recruitment rate was 60 out of 117 patients (51.3%). Nevertheless, the dropout rate of 10% was within the acceptable range. Patients were aged between 21 and 74 years. Nearly 50 of the patients (>85%) had adequate health literacy and exposure to stroke education. Most of the patients (>80%) were diagnosed with ischemic stroke, whereby the majority had primary hypertension. The technicalities of randomization and patient approach were carried out with minimal challenge and adequate patient satisfaction. The video contents received good responses with respect to comprehension and simplicity. Moreover, an in-depth phone interview with 8 patients indicated that the video narratives were considered to be useful and inspiring. These findings paralleled the preliminary findings of significant improvement within groups in MUSE (P=.001) and systolic blood pressure control (P=.04). CONCLUSIONS The queries and feedback from each phase in this study have been acknowledged and will be taken forward in the full trial. CLINICALTRIAL Australian New Zealand Clinical Trials Registry ACTRN 12618000174280; https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=373554
- Open Access
- 21 August 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Feasibility and Acceptability of Video narratives intervention to Promote Medication Understanding and Use Self-Efficacy: A Pilot Study on Post-Stroke Patients (Preprint)
BACKGROUND A large number of the world’s post-stroke survivors suffers from moderate to severe disability. Long-term uncontrolled stroke risk factor led to unforeseen recurrent stroke and a growing number of stroke occurrence across ages in Malaysia. This situation has led to research works tapping into patient education, especially related to the self-efficacy of understanding and taking medication appropriately. Video narratives integrated with Health Belief Model (HBM) constructs have displayed potential impact as an aide to patient education efforts. OBJECTIVE This pilot study aimed to investigate the feasibility and acceptability of study procedures based on a trial protocol of video narratives intervention among post-stroke patients. In this paper, we report the preliminary efficacy of video narratives on medication understanding and use self-efficacy (MUSE). METHODS A parallel-group, randomized controlled study was conducted at the neurology outpatient clinic on post-stroke patients (N=54). Baseline data included patients’ socio-demographics, medical information, and all outcome measures. Post measurement of MUSE and blood parameters were done during 3 months follow-up. Feasibility of the study included recruitment and study completion rate with patients’ feedback on the burden of study procedures and outcome measures. Whereas, acceptability of study were analyzed qualitatively. Few statistical analyses were applied to ascertain preliminary results of the video narratives. RESULTS The recruitment rate was (60/157) 38%. Nevertheless, the dropout rate of (6/60) 10% was within the acceptable range. Patients were aged between 21 and 74 years. Over 85% of them had adequate health literacy and exposure to stroke education. Most patients (> 80%) were diagnosed with ischemic stroke whereby the majority were primarily hypertensive. The technicality of randomization and patient approach were carried out with minimal challenge and adequate patient satisfaction. However, the burden of outcome measures received some concerns. The video contents received good responses about its comprehension and simplicity. Moreover, an in-depth phone interview with 8 patients found the video narratives useful and inspiring. This findings also paralleled significant preliminary improvement in MUSE (P<0.05). CONCLUSIONS The queries and feedback noted from each study’s phase in the pilot study had been acknowledged, and thus, convincingly would be taken forward to the full trial. CLINICALTRIAL Universal Trial Number (UTN) U1111-1201-3955
- 21 August 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessFeasibility and Acceptability of Video narratives intervention to Promote Medication Understanding and Use Self-Efficacy: A Pilot Study on Post-Stroke Patients (Preprint)
BACKGROUND A large number of the world’s post-stroke survivors suffers from moderate to severe disability. Long-term uncontrolled stroke risk factor led to unforeseen recurrent stroke and a growing number of stroke occurrence across ages in Malaysia. This situation has led to research works tapping into patient education, especially related to the self-efficacy of understanding and taking medication appropriately. Video narratives integrated with Health Belief Model (HBM) constructs have displayed potential impact as an aide to patient education efforts. OBJECTIVE This pilot study aimed to investigate the feasibility and acceptability of study procedures based on a trial protocol of video narratives intervention among post-stroke patients. In this paper, we report the preliminary efficacy of video narratives on medication understanding and use self-efficacy (MUSE). METHODS A parallel-group, randomized controlled study was conducted at the neurology outpatient clinic on post-stroke patients (N=54). Baseline data included patients’ socio-demographics, medical information, and all outcome measures. Post measurement of MUSE and blood parameters were done during 3 months follow-up. Feasibility of the study included recruitment and study completion rate with patients’ feedback on the burden of study procedures and outcome measures. Whereas, acceptability of study were analyzed qualitatively. Few statistical analyses were applied to ascertain preliminary results of the video narratives. RESULTS The recruitment rate was (60/157) 38%. Nevertheless, the dropout rate of (6/60) 10% was within the acceptable range. Patients were aged between 21 and 74 years. Over 85% of them had adequate health literacy and exposure to stroke education. Most patients (> 80%) were diagnosed with ischemic stroke whereby the majority were primarily hypertensive. The technicality of randomization and patient approach were carried out with minimal challenge and adequate patient satisfaction. However, the burden of outcome measures received some concerns. The video contents received good responses about its comprehension and simplicity. Moreover, an in-depth phone interview with 8 patients found the video narratives useful and inspiring. This findings also paralleled significant preliminary improvement in MUSE (P<0.05). CONCLUSIONS The queries and feedback noted from each study’s phase in the pilot study had been acknowledged, and thus, convincingly would be taken forward to the full trial. CLINICALTRIAL Universal Trial Number (UTN) U1111-1201-3955
- Open Access
- 22 July 2019
- Published by JMIR Publications Inc. in JMIR Nursing
- Vol. 2 (1) , e14399
The Needs and Barriers of Medication-Taking Self-Efficacy Among Poststroke Patients: Qualitative Study
Background: Stroke is one of the top 10 leading diseases worldwide, with high mortality and morbidity rates. There is an incomplete understanding of the various types of self-efficacy involved in the prevention of recurrent stroke, and one of them is medication-taking self-efficacy.Objective: This study aimed to explore the fundamental needs and barriers of medication-taking self-efficacy in poststroke patients in Malaysia.Methods: We performed in-depth individual interviews with poststroke patients (N=10) from the Outpatient Neurology Clinic, Hospital Kuala Lumpur. All interviews were transcribed verbatim, and an inductive thematic analysis was performed on the data collected from the interviews.Results: Two key themes were identified: (1) self-efficacy in taking the effort to understand stroke and its preventative treatment for recurrent stroke and (2) self-efficacy in taking prescribed medication to prevent stroke. Patients needed to be proactive in seeking reliable information about stroke and the perceived benefits of preventative treatment for stroke. The discussion was focused on eliciting the needs and barriers related to medication-taking self-efficacy. Patients needed to develop independence and self-reliance to overcome barriers such as dependency and low motivation. External factors such as limited information resources, low perceived severity, poor social environment, and poor communication add to the challenges of poststroke patients to improve their self-efficacy of managing their medications.Conclusions: The study identified potential key findings related to the needs of patients in a localized setting, which are also related to several health behavioral concepts and constructs, indicating the importance of overcoming barriers to improve the quality of life in poststroke patients. We anticipate that the results will be taken into consideration for future personalized patient education interventions.
- 22 July 2019
- Published by JMIR Publications Inc. in JMIR Nursing
- Vol. 2 (1) , e14399
Open AccessThe Needs and Barriers of Medication-Taking Self-Efficacy Among Poststroke Patients: Qualitative Study
Background: Stroke is one of the top 10 leading diseases worldwide, with high mortality and morbidity rates. There is an incomplete understanding of the various types of self-efficacy involved in the prevention of recurrent stroke, and one of them is medication-taking self-efficacy.Objective: This study aimed to explore the fundamental needs and barriers of medication-taking self-efficacy in poststroke patients in Malaysia.Methods: We performed in-depth individual interviews with poststroke patients (N=10) from the Outpatient Neurology Clinic, Hospital Kuala Lumpur. All interviews were transcribed verbatim, and an inductive thematic analysis was performed on the data collected from the interviews.Results: Two key themes were identified: (1) self-efficacy in taking the effort to understand stroke and its preventative treatment for recurrent stroke and (2) self-efficacy in taking prescribed medication to prevent stroke. Patients needed to be proactive in seeking reliable information about stroke and the perceived benefits of preventative treatment for stroke. The discussion was focused on eliciting the needs and barriers related to medication-taking self-efficacy. Patients needed to develop independence and self-reliance to overcome barriers such as dependency and low motivation. External factors such as limited information resources, low perceived severity, poor social environment, and poor communication add to the challenges of poststroke patients to improve their self-efficacy of managing their medications.Conclusions: The study identified potential key findings related to the needs of patients in a localized setting, which are also related to several health behavioral concepts and constructs, indicating the importance of overcoming barriers to improve the quality of life in poststroke patients. We anticipate that the results will be taken into consideration for future personalized patient education interventions.
- Open Access
- 15 April 2019
- Published by JMIR Publications Inc. in JMIR Preprints
The Needs and Barriers of Medication-Taking Self-Efficacy Among Poststroke Patients: Qualitative Study (Preprint)
BACKGROUND Stroke is one of the top 10 leading diseases worldwide, with high mortality and morbidity rates. There is an incomplete understanding of the various types of self-efficacy involved in the prevention of recurrent stroke, and one of them is medication-taking self-efficacy. OBJECTIVE This study aimed to explore the fundamental needs and barriers of medication-taking self-efficacy in poststroke patients in Malaysia. METHODS We performed in-depth individual interviews with poststroke patients (N=10) from the Outpatient Neurology Clinic, Hospital Kuala Lumpur. All interviews were transcribed verbatim, and an inductive thematic analysis was performed on the data collected from the interviews. RESULTS Two key themes were identified: (1) self-efficacy in taking the effort to understand stroke and its preventative treatment for recurrent stroke and (2) self-efficacy in taking prescribed medication to prevent stroke. Patients needed to be proactive in seeking reliable information about stroke and the perceived benefits of preventative treatment for stroke. The discussion was focused on eliciting the needs and barriers related to medication-taking self-efficacy. Patients needed to develop independence and self-reliance to overcome barriers such as dependency and low motivation. External factors such as limited information resources, low perceived severity, poor social environment, and poor communication add to the challenges of poststroke patients to improve their self-efficacy of managing their medications. CONCLUSIONS The study identified potential key findings related to the needs of patients in a localized setting, which are also related to several health behavioral concepts and constructs, indicating the importance of overcoming barriers to improve the quality of life in poststroke patients. We anticipate that the results will be taken into consideration for future personalized patient education interventions.
- 15 April 2019
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessThe Needs and Barriers of Medication-Taking Self-Efficacy Among Poststroke Patients: Qualitative Study (Preprint)
BACKGROUND Stroke is one of the top 10 leading diseases worldwide, with high mortality and morbidity rates. There is an incomplete understanding of the various types of self-efficacy involved in the prevention of recurrent stroke, and one of them is medication-taking self-efficacy. OBJECTIVE This study aimed to explore the fundamental needs and barriers of medication-taking self-efficacy in poststroke patients in Malaysia. METHODS We performed in-depth individual interviews with poststroke patients (N=10) from the Outpatient Neurology Clinic, Hospital Kuala Lumpur. All interviews were transcribed verbatim, and an inductive thematic analysis was performed on the data collected from the interviews. RESULTS Two key themes were identified: (1) self-efficacy in taking the effort to understand stroke and its preventative treatment for recurrent stroke and (2) self-efficacy in taking prescribed medication to prevent stroke. Patients needed to be proactive in seeking reliable information about stroke and the perceived benefits of preventative treatment for stroke. The discussion was focused on eliciting the needs and barriers related to medication-taking self-efficacy. Patients needed to develop independence and self-reliance to overcome barriers such as dependency and low motivation. External factors such as limited information resources, low perceived severity, poor social environment, and poor communication add to the challenges of poststroke patients to improve their self-efficacy of managing their medications. CONCLUSIONS The study identified potential key findings related to the needs of patients in a localized setting, which are also related to several health behavioral concepts and constructs, indicating the importance of overcoming barriers to improve the quality of life in poststroke patients. We anticipate that the results will be taken into consideration for future personalized patient education interventions.
- Open Access
- 13 April 2019
- Published by IntechOpen
Diagnosis of Multiple Sclerosis
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. Although there are no pathognomonic features to confirm the diagnosis of this immune-mediated disease, a constellation of clinical, radiological, and immune studies can ensure the clinician gets a more definitive diagnosis. Criteria have been made every few years based on research to clinch the diagnosis. The most recent criteria which are the McDonald criteria have been formed in 2001 and revised in 2005, 2010, and 2017. Most criteria are to be used only as a guide to facilitate the diagnosis of multiple sclerosis. Advances in demyelinating disorders will require diagnostic criteria to be revised every few years with scientists hoping for a more definitive and confirmative diagnosis. The cardinal features for diagnosis are dissemination in time and space. There should be no other possible explanation to the clinical features.
- 13 April 2019
- Published by IntechOpen
Open AccessDiagnosis of Multiple Sclerosis
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disorder of the central nervous system. Although there are no pathognomonic features to confirm the diagnosis of this immune-mediated disease, a constellation of clinical, radiological, and immune studies can ensure the clinician gets a more definitive diagnosis. Criteria have been made every few years based on research to clinch the diagnosis. The most recent criteria which are the McDonald criteria have been formed in 2001 and revised in 2005, 2010, and 2017. Most criteria are to be used only as a guide to facilitate the diagnosis of multiple sclerosis. Advances in demyelinating disorders will require diagnostic criteria to be revised every few years with scientists hoping for a more definitive and confirmative diagnosis. The cardinal features for diagnosis are dissemination in time and space. There should be no other possible explanation to the clinical features.
- Open Access
- 5 July 2017
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 7 (2) , 1-3
A Rare Case Of Cavernous Sinus Syndrome in a Patient with Tuberculous Meningitis
Cavernous sinus syndrome is a rare manifestation of Tuberculous (TB) meningitis. Initial MRI finding may be normal despite clinical manifestation of complex ophthalmoplegia. Early diagnosis and commencement of tuberculous treatment is crucial as it effects the rate of nerve recovery. A case of 33 year old Malay gentleman, presented with symptoms associated with elevated intracranial pressure and isolated left sixth nerve palsy which then evolved to complex ophthalmoplegia. Initial MRI brain done revealed no abnormality. Elevated CSF (Cerebrospinal Fluid) protein with raised ESR (Erythrocyte Sedimentation Rate) and repeated MRI (Magnetic Resonance Imaging) which showed inflammatory changes over bilateral cavernous sinus and surrounding structure raised high index suspicion of TB meningitis. He was empirically treated with anti TB medication and he responded well. Further review of repeated MRI orbit and patient revealed resolution left sixth nerve palsy and resolution of inflammation over both cavernous sinus.
- 5 July 2017
- Published by MedCrave Group Kft. in Journal of Neurology & Stroke
- Vol. 7 (2) , 1-3
Open AccessA Rare Case Of Cavernous Sinus Syndrome in a Patient with Tuberculous Meningitis
Cavernous sinus syndrome is a rare manifestation of Tuberculous (TB) meningitis. Initial MRI finding may be normal despite clinical manifestation of complex ophthalmoplegia. Early diagnosis and commencement of tuberculous treatment is crucial as it effects the rate of nerve recovery. A case of 33 year old Malay gentleman, presented with symptoms associated with elevated intracranial pressure and isolated left sixth nerve palsy which then evolved to complex ophthalmoplegia. Initial MRI brain done revealed no abnormality. Elevated CSF (Cerebrospinal Fluid) protein with raised ESR (Erythrocyte Sedimentation Rate) and repeated MRI (Magnetic Resonance Imaging) which showed inflammatory changes over bilateral cavernous sinus and surrounding structure raised high index suspicion of TB meningitis. He was empirically treated with anti TB medication and he responded well. Further review of repeated MRI orbit and patient revealed resolution left sixth nerve palsy and resolution of inflammation over both cavernous sinus.
- Open Access
- 31 July 2016
- Published by SAGE Publications in Proceedings of Singapore Healthcare
- Vol. 26 (1) , 58-61
A severe anti-NMDA-receptor encephalitis case with extensive cortical and white matter changes, cerebral atrophy and communicating hydrocephalus
A 21-year-old woman presented with a viral prodrome, abnormal behaviours, confusion and short-term memory loss, followed by status epilepticus that later evolved to orofacial dyskinesias, autonomic dysfunctions and hypoventilation requiring prolonged ventilator support and ICU admission. Cerebrospinal fluid (CSF) and serum analysis confirmed the presence of anti-NMDAR autoantibodies. A left salpingoopherectomy was performed on day 35 of admission revealing an immature ovarian teratoma. Following surgical and two courses of intravenous immunoglobulin therapy, her response remained poor. Initial brain magnetic resonance imaging (MRI) during the acute stage showed enlarged left hippocampus. Further MRI follow-up 13 weeks after admission showed unusual findings of extensive cortical and white matter changes, generalised cerebral atrophy, dilated ventricles and possible transependymal CSF seepage of communicating hydrocephalus. A ventriculo-peritoneal shunt was performed subsequently and she was discharged 6 months after admission without significant change in her clinical status. Follow-up 4 months later showed some improvement but patient remained severely disabled.
- 31 July 2016
- Published by SAGE Publications in Proceedings of Singapore Healthcare
- Vol. 26 (1) , 58-61
Open AccessA severe anti-NMDA-receptor encephalitis case with extensive cortical and white matter changes, cerebral atrophy and communicating hydrocephalus
A 21-year-old woman presented with a viral prodrome, abnormal behaviours, confusion and short-term memory loss, followed by status epilepticus that later evolved to orofacial dyskinesias, autonomic dysfunctions and hypoventilation requiring prolonged ventilator support and ICU admission. Cerebrospinal fluid (CSF) and serum analysis confirmed the presence of anti-NMDAR autoantibodies. A left salpingoopherectomy was performed on day 35 of admission revealing an immature ovarian teratoma. Following surgical and two courses of intravenous immunoglobulin therapy, her response remained poor. Initial brain magnetic resonance imaging (MRI) during the acute stage showed enlarged left hippocampus. Further MRI follow-up 13 weeks after admission showed unusual findings of extensive cortical and white matter changes, generalised cerebral atrophy, dilated ventricles and possible transependymal CSF seepage of communicating hydrocephalus. A ventriculo-peritoneal shunt was performed subsequently and she was discharged 6 months after admission without significant change in her clinical status. Follow-up 4 months later showed some improvement but patient remained severely disabled.